MIRA INFORM REPORT

 

 

Report No. :

348084

Report Date :

07.11.2015

 

IDENTIFICATION DETAILS

 

Name :

COPERMED COMERCIAL IMPORTADORA LTDA

 

 

Registered Office :

Rua Dr. Murilo Carvalho Coutinho, 90 Bairro Fatima Iii, 37500-000 - Pouso Alegre/Mg

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

09.07.2007

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Wholesale of pharmaceuticals

 

 

No. of Employee :

15

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, and a rapidly expanding middle class, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. Since 2008, Brazil became a net external creditor and all three of the major ratings agencies awarded investment grade status to its debt.

After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. GDP growth has slowed since 2011, due to several factors, including: overdependence on exports of raw commodities, low productivity, high operational costs, persistently high inflation, and low levels of investment. After reaching historic lows of 4.5% in early 2014, the unemployment rate remains low, but is rising. Brazil's traditionally high level of income inequality has declined for each of the last 15 years.

Brazil’s fiscal and current account balances have eroded during the past four years as the government attempted to boost economic growth through targeted tax cuts for industry and incentives to spur household consumption. After winning reelection in October 2014 by a historically narrow margin, President Dilma ROUSSEFF appointed a new economic team led by Finance Minister Joaquim LEVY, who introduced a fiscal austerity package intended to restore the primary account surplus to 1.2% of GDP and preserve the country's investment-grade sovereign credit rating.

Brazil seeks to strengthen its workforce and its economy over the long run by imposing local content and technology transfer requirements on foreign businesses, by investing in education through social programs such as Bolsa Familia and the Brazil Science Mobility Program, and by investing in research in the areas of space, nanotechnology, healthcare, and energy.

 

Source : CIA

 

Company name

 

COPERMED COMERCIAL IMPORTADORA LTDA

 

 

ADDRESSES

 

MAIN ADDRESS:

RUA DR. MURILO CARVALHO COUTINHO, 90 BAIRRO FATIMA III

ZIP CODE/CITY:

37500-000 - POUSO ALEGRE/MG

 

 

PHONE:

35 3422-9744

FAX:

35 3422-9744

E-MAIL:

copermed@bol.com.br

WEB SITE:

www.copermed.com

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA PINTO COBRA, 370 VILA MARIANA

ZIP CODE/CITY:

37550-000 POUSO ALEGRE/RS

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

WHOLESALE OF PHARMACEUTICALS.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

09/07/2007

REGISTER DATE:

09/07/2007

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

09.029.404/0001-82

STATE REGISTER:

001.042.00000-97

 

 

SHARE CAPITAL:

R$ 2.700.000,00

 

BOARD OF DIRECTORS:

 

 

 

BRUNO ALEXANDRE DEMORI

MANAGING PARTNER

 

 

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

ANGELO EURICO DEMORI (DECEASED)

99%

BRUNO ALEXANDRE DEMORI

1%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

NO SHARE INTERESTS IN OTHER COMPANIES WERE NOTED

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JULY 9, 2007 AS COPREMED COMERCIO DE PERFUMARIA E MEDICAMENTOS LTDA. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. LATER IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

BUSINESS ADDRESS HAS CHANGED FROM (RODOVIA JK, KM (BR 459), 111 S/Nº - BAIRRO DOS CHAVES, POUSO ALEGRE/MG) TO THE PRESENT REGISTERED ONE.

 

TRADE NAME: "COPERMED"

 

PARTNERS:

 

ANGELO EURICO DEMORI: REPRESENTED BY BRUNO ALEXANDRE DEMORI

 

BRUNO ALEXANDRE DEMORI: BRAZILIAN, SINGLE, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF 376.360.938-55 AND RG 44.553.570-2, SSP/SP, RESIDENTIAL ADDRESS AT RODOVIA J.K. 111, S/Nº. BAIRRO DOS CHAVES, ZIP CODE 37550-000, POUSO ALEGRE/MG.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

FEDERAL LAWSUIT

01/12/14

1ª VARA DE MG-POUSO ALEGRE

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

CASH AND CASH EQUIVALENTS

6.769,93

86.339,94

59.595,48

CLIENTS

26.573.723,60

291.816,90

876.281,64

ADVANCE TO SUPPLIERS

 

 

46.022,54

ADVANCES

80.310,10

57.050,59

25.512,74

RECOVERABLE TAXES

805.266,21

1.333.236,24

304.594,08

INVENTORY

3.523.118,20

2.889.230,36

1.650.059,15

ADVANCE TO EMPLOYEES

 

43.700,00

43.700,00

DISCOUNTED NOTES

-26.568.656,74

 

 

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

4.420.531,30

4.701.374,03

3.005.765,63

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

ACCOUNTS RECEIVABLES

495.193,85

495.193,85

495.193,85

JUDICIAL DEPOSITS

35.433,01

35.433,01

35.433,01

OTHER CREDITS

 

858.705,78

242.616,62

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

530.626,86

1.389.332,64

773.243,48

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

2.571.235,81

1.025.167,61

460.349,64

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

2.571.235,81

1.025.167,61

460.349,64

 

================

================

================

TOTAL ASSETS

7.522.393,97

7.115.874,28

4.239.358,75

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

LABOR OBLIGATIONS

42.998,99

84.528,63

104.905,54

TRIBUTARY OBLIGATIONS

470.343,64

567.551,34

240.574,76

FINANCING

110.000,00

1.499.215,58

 

SUPPLIERS

2.268.225,07

2.508.487,52

2.378.971,78

OTHER

800.000,00

1.804,29

101,39

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

3.691.567,70

4.661.587,36

2.724.553,47

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

6.158,86

6.158,86

138.949,38

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

6.158,86

6.158,86

138.949,38

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

2.700.000,00

12.600,00

12.600,00

ACCRUED PROFIT (LOSS)

1.124.667,41

2.435.528,06

1.363.255,90

 

----------------

----------------

----------------

TOTAL NET EQUITY

3.824.667,41

2.448.128,06

1.375.855,90

 

================

================

================

TOTAL LIABILITIES

7.522.393,97

7.115.874,28

4.239.358,75

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012.

( FIGURES ARE IN REAIS ).

 

 

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

GROSS SALES

21.036.443,09

17.886.865,26

9.655.329,15

(-) TAXES ON SALES

2.082.568,27

1.475.147,40

980.734,18

 

----------------

----------------

----------------

NET SALES

18.953.874,82

16.411.717,86

8.674.594,97

(-) COST OF SOLD GOODS

13.293.242,36

10.182.941,88

4.798.505,38

 

----------------

----------------

----------------

GROSS PROFIT

5.660.632,46

6.228.775,98

3.876.089,59

OPERATING REVENUE (EXPENSE)

-3.464.832,94

-4.257.045,42

-2.451.296,88

FINANCIAL REVENUE(EXPENSE)

-194.183,90

-129.671,76

-86.844,09

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

2.001.615,62

1.842.058,80

1.337.948,62

NON-OPERATING RESULT

-1.140,71

 

-476,71

CONTRIBUTION/INCOME TAX

-623.935,56

-769.786,64

-265.909,73

 

----------------

----------------

----------------

NET PROFIT (LOSS)

1.376.539,35

1.072.272,16

1.071.562,18

 

MONTHLY SALES

 

  2015

 

 

 

---------------------

---------------------

 

JANUARY

R$ 725.189,87

 

 

FEBRUARY

R$ 1.550.190,31

 

 

MARCH

R$ 2.178.104,40

 

 

APRIL

R$ 1.058.334,76

 

 

MAY

R$ 643.061,58

 

 

JUNE

R$ 1.545.726,66

 

 

JULY

R$ 1.087.776,14

 

 

AUGUST

 

 

 

SEPTEMBER

 

 

 

OCTOBER

 

 

 

NOVEMBER

 

 

 

DECEMBER

 

 

 

TOTAL

R$ 8.788.383,72

 

 

 

RATIOS:

31/12/2014

31/12/2013

31/12/2012

 

QUICK RATIO

,24

 

,39

 

,50

 

CURRENT RATIO

1,20

 

1,01

 

1,10

 

ACCOUNTS RECEIVABLE TURNOVER

,71

TIMES

56,24

TIMES

9,90

TIMES

DAYS' SALES IN RECEIVABLES

504,73

DAYS

6,40

DAYS

36,37

DAYS

INVENTORY TURNOVER

3,77

TIMES

3,52

TIMES

2,91

TIMES

ACCOUNTS PAYABLE PERIOD

61,43

DAYS

88,68

DAYS

178,48

DAYS

RETURN ON ASSETS

2,52

TIMES

2,31

TIMES

2,05

TIMES

SALES TURNOVER ON NET EQUITY

4,96

TIMES

6,70

TIMES

6,30

TIMES

NET WORTH TIE-UP

,67

 

,42

 

,33

 

INDEBTEDNESS

,97

 

1,91

 

2,08

 

EQUITY RATIO

50,84

%

34,40

%

32,45

%

WORKING CAPITAL RATIO

19,75

%

,85

%

10,32

%

GENERAL SOLVENCY

2,03

 

1,52

 

1,48

 

RETURN ON NET EQUITY

35,99

%

43,80

%

77,88

%

RETURN ON SALES (PROFIT MARGIN)

7,26

%

6,53

%

12,35

%

GROSS PROFIT MARGIN

29,87

%

37,95

%

44,68

%

OPERATIONAL RESULT

10,56

%

11,22

%

15,42

%

SALES TURNOVER ON LIABILITIES

5,13

TIMES

3,52

TIMES

3,18

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 3,81

 - OFFICIAL RATE ON 03/11/2015

US$ 1,00 = R$ 2,65

 - OFFICIAL RATE ON 31/12/2014

US$ 1,00 = R$ 2,34

 - OFFICIAL RATE ON 31/12/2013

US$ 1,00 = R$ 2,04

 - OFFICIAL RATE ON 31/12/2012

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS SOMEHOW HIGH BUT IT HAS NORMAL CURRENT RATIO AND POSITIVE WORKING CAPITAL, CONSIDERED SUFFICIENT TO COVER THE SHORT TERM DEBTS. IT ALSO SHOWS HIGH GROWING SALES AND PROFITABILITY.

 

THE INCREASE IN THE SALES VOLUME WAS ATTRIBUTABLE TO THE INCREASE OF THE DEMAND.

 

REAL ESTATE:

 

OWNED PREMISES ARE VALUED AT R$ 2.571.235,81

 

THE PARTNERS OWN REAL ESTATE VALUED AT  R$ 350.000,00

 

VEHICLES:

 

 OWNED VEHICLES ARE VALUED AT R$ 324.465,00

 

MACHINES

 

   OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 68.134,90

 

 

INSURANCE

 

INSURANCE COMPANY:

BRADESCO SEGUROS

COVERAGE:

INVENTORY (ROBBERY / FIRE)

VALUE:

R$ 500.000,00

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO SANTANDER (BRASIL) S/A

3255  /   35 3429-7100

 

BANCO ITAÚ S/A

7347

POUSO ALEGRE/MG

BANCO DO BRASIL S/A

0368-9   /   35 3449-4600

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

WHOLESALE OF PHARMACEUTICALS.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

INDIA AND EUROPE.

 

 EXPORTS TO:

ARGENTINA, URUGUAY, PARAGUAY AND CHILE.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

PHONE:

ADRIVAN

 

11 4043-0411

BELFAR INDUSTRIA FARMACEUTICA

 

31 3492-1100

CIMED INUSTRIA MEDICAMENTOS LTDA

 

11 3544-7200

FAGRON DO BRASIL FARMACEUTICA LTDA

 

11 5033-3700

HYPERMARCAS S/A

 

62 3310-2500

HYPOFARMA INST. HYPODERMA

 

31 3626-9019

LABORATORIO TEUTO

 

62 3310-2088

MEDQUIMICA

 

32 3222-1433

NEO QUIMICA

 

62 3310-2400

NOVAFARMA INDUSTRIA FARMACEUTIVA

 

62 3310-8200

ROYTON INDUSTRIA FARMACEUTICA

 

11 2107-9008

VALDEQUIMICA PRODUTOS QUIMICOS

 

11 3721-6407

 

STAFF:

 

THE COMPANY HAS: 15 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 2007. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES.

 

THE LAWSUIT REPORTED IS NOT RELATED WITH TRADE DEBT. IT IS RELATED TO TAX DEBT THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUIT DOES NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

 

LABORIS FARMACEUTICA LTDA

 

 

OURO FINO SAUDE ANIMAL LTDA

 

16 3518-2326

PAULINERIS TRANSPORTES E ENCOMENDAS LTDA

 

35 3422-8935

PHARMASAIS COM. DIS. ESP.FARMACEUTICA LTDA

 

11 3806-1760

TRANSPALLET TRANSPORTES E LOGISTICA LTDA

 

11 2445-5515

 

FOREIGN SUPPLIERS:

COUNTRY:

 

DP PHARM CHEM

GERMANY

 

INDOCO REMEDIES

INDIA

 

JIANGSU GUOTAI INTERN. GROUP

CHINA

 

LACTOSE INDIA LTD

INDIA

 

SHAANXI TIANRUN PHYTOCHEMICAL CO

 

 

SINOCHEM LIAONING CORPORATION

CHINA

 

SURYA PHARMACEUTICALS

INDIA

 

TECNHO DRUGS POLYDUGCOS

 

 

VUAB FARMA AS

 

 

 

PAYMENT HISTORY:

 

5 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 153.546,00

 

AMOUNT OF INVOICES PAID: 15

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 33.390,00

HIGHEST CREDIT: R$ 33.390,00

 

 

FINAL OPINION

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.79

UK Pound

1

Rs.99.95

Euro

1

Rs.71.55

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ASH

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.